BamSEC and AlphaSense Join Forces
Learn More

Vistagen Therapeutics Inc.

NASDAQ: VTGN    
Share price (1/6/25): $3.20    
Market cap (1/6/25): $89.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.163
from 10-K 10 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 1 page Amendment No. 4 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 8-K 6 pages Exclusive Negotiation Agreement
12/34/56
EX-10.162
from 10-K 2 pages Amendment No. 1 to Master Services Agreement (For All Cro Services) Amendment
12/34/56
EX-10.161
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.159
from 10-K 2 pages Amendment No. 3 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 10-Q 2 pages Amendment No. 2 to Consulting Services Agreement Amendment
12/34/56
EX-10.3
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Amendment No. 1 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 10-Q 7 pages Consulting Services Agreement
12/34/56
EX-10.1
from 10-Q 6 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Third Amendment to Lease
12/34/56
EX-10.1
from 8-K 7 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 7 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10
from 8-K 7 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 56 pages License and Collaboration Agreement Between VistaGen Therapeutics, Inc. and Everinsight Therapeutics Inc
12/34/56
EX-10.1
from 8-K 77 pages Recitals Article 1 Definitions
12/34/56
EX-10
from 8-K 7 pages Silicon Valley Bank U.S. Small Business Administration Paycheck Protection Program Note
12/34/56
EX-10
from 8-K 13 pages Registration Rights Agreement
12/34/56
EX-10
from 8-K 37 pages Purchase Agreement
12/34/56